Featured Press Releases

SystImmune secures FDA clearance for BL-M17D1 IND in advanced solid tumors

SystImmune secures FDA clearance for BL-M17D1 IND in advanced solid tumors

Kiromic BioPharma reports positive results from third patient in Deltacel-01 trial

Kiromic BioPharma reports positive results from third patient in Deltacel-01 trial

  • 02 Apr 2024

Kiromic BioPharma, Inc. reports early efficacy results showing tumor stabilization in the third...

Eisai submitted a rolling sBLA to the U.S. FDA for LEQEMBI® IQLIK™ as a subcutaneous starting dose to treat early Alzheimer’s, under Fast Track status

Eisai submitted a rolling sBLA to the U.S. FDA for LEQEMBI® IQLIK™ as a subcutaneous starting dose to treat early Alzheimer’s, under Fast Track status

Long Island University alumnus Dr. Howard Murad

Long Island University alumnus Dr. Howard Murad '62 launches the Inclusive Wellness Initiative with the Arnold & Marie Schwartz College of Pharmacy and Health Sciences

Nuvation Bio unveils new data on IBTROZI™ (taletrectinib) in advanced ROS1-positive non-small cell lung cancer

Nuvation Bio unveils new data on IBTROZI™ (taletrectinib) in advanced ROS1-positive non-small cell lung cancer

Matisse Pharmaceuticals receives INN for M6229, recognizing it as a first-in-class drug, isupartob sodium

Matisse Pharmaceuticals receives INN for M6229, recognizing it as a first-in-class drug, isupartob sodium

CoreAge Rx broadens GLP-1 access in support of New Year weight loss initiatives

CoreAge Rx broadens GLP-1 access in support of New Year weight loss initiatives

  • CoreAge Rx
  • 21 Jan 2026
OCuSOFT Inc. introduces Retaine® Omega Forté™, a liquid supplement designed to deliver superior nutritional support in the management of dry eye

OCuSOFT Inc. introduces Retaine® Omega Forté™, a liquid supplement designed to deliver superior nutritional support in the management of dry eye

  • OCuSOFT Inc.
  • 20 Jan 2026
BIOCORNEUM® announces the availability of its new dual-action bruise system designed to enhance post-procedure recovery

BIOCORNEUM® announces the availability of its new dual-action bruise system designed to enhance post-procedure recovery

  • BIOCORNEUM
  • 15 Jan 2026
MTF Biologics and Kolosis BIO introduce Summit Matrix™, expanding solutions for orthopedic and spinal surgeries

MTF Biologics and Kolosis BIO introduce Summit Matrix™, expanding solutions for orthopedic and spinal surgeries

  • MTF Biologics
  • 15 Jan 2026
First National Campaign Launched by Trauma Intervention Programs (TIP)

First National Campaign Launched by Trauma Intervention Programs (TIP)

  • Avrek Law Firm
  • 14 Jan 2026
Lansinoh® Launched NaturalWave® Double Electric Breast Pump Featuring Exclusive Flutter Technology for Increased Milk Output

Lansinoh® Launched NaturalWave® Double Electric Breast Pump Featuring Exclusive Flutter Technology for Increased Milk Output

  • Lansinoh
  • 14 Jan 2026
Drug Discovery 2024
The Digital Pharma Advances Conference 2026

Most Popular
January   2026
M T W T F S S
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.